Glossary
Allocation concealed: deemed to have taken adequate measures to conceal allocation to study group assignments from those responsible for assessing patients for entry in the trial (eg, central randomisation; sequentially numbered, opaque, sealed envelopes; sealed envelopes from a closed bag; numbered or coded bottles or containers; drugs prepared by the pharmacy; or other descriptions that contain elements convincing of concealment).
Allocation not concealed: deemed to have not taken adequate measures to conceal allocation to study group assignments from those responsible for assessing patients for entry in the trial (eg, no concealment procedure was undertaken, sealed envelopes that were not opaque, or other descriptions that contain elements not convincing of concealment).
Unclear allocation concealment: the authors of the article did not report or provide us with a description of an allocation concealment approach that allowed for classification as concealed or not concealed.
Blinded: any or all of the clinicians, patients, participants, outcome assessors, or statisticians were unaware of who received which study intervention. Those that are blinded are indicated in parentheses. If "initially" is indicated (eg, blinded [patients and outcome assessor initially]), the code was broken during the trial, for instance, because of adverse effects.
Blinded (unclear): the authors did not report or provide us with an indication of who, if anyone, was unaware of who received which study intervention.
Unblinded: all participants in the trial (clinicians, patients, participants, outcome assessors, and statisticians) were aware of who received which study intervention.
RRR (relative risk reduction): the proportional reduction in rates of bad events between experimental (experimental event rate [EER]) and control (control event rate [CER]) patients in a trial, calculated as |EER-CER|/CER and accompanied by a 95% confidence interval (CI).
ARR (absolute risk reduction): the absolute arithmetic difference in event rates, |EER-CER|
NNT (number needed to treat): the number of patients who need to be treated to prevent one additional bad outcome; calculated as 1/ARR, rounded up to the next highest whole number, and accompanied by its 95% CI.
RBI (relative benefit increase): the increase in the rates of good events, comparing experimental and control patients in a trial, also calculated as |EER-CER|/CER.
ABI (absolute benefit increase): the absolute arithmetic difference in event rates, |EER-CER|.
NNT: calculated as 1/ABI; denotes the number of patients who must receive the experimental treatment to create one additional improved outcome in comparison with the control treatment.
RRI (relative risk increase): the increase in rates of bad events, comparing experimental patients to control patients in a trial, and calculated as for RBI. RRI is also used in assessing the effect of risk factors for disease.
ARI (absolute risk increase): the absolute difference in rates of bad events, when the experimental treatment harms more patients than the control treatment; calculated as for ABI.
NNH (number needed to harm): the number of patients who, if they received the experimental treatment, would lead to one additional person being harmed compared with patients who receive the control treatment; calculated as 1/ARI.
Confidence interval (CI): the CI quantifies the uncertainty in measurement; usually reported as 95% CI, which is the range of values within which we can be 95% sure that the true value for the whole population lies.
Weighted event rates: the contributions of individual studies to the total in a meta-analysis, determined by the sample size and the number of events in each study.
Sensitivity: the proportion of patients with the target disorder who have a positive test result (a/[a + c]) (figure).
Specificity: the proportion of patients without the target disorder who have a negative test result (d/[b + d]) (figure).
Pretest probability (prevalence): the proportion of patients who have the target disorder, as determined before the test is carried out ([a + c]/[a + b + c + d]) (figure).
Pretest odds: the odds that the patient has the target disorder before the test is carried out (pretest probability/[1 — pretest probability]).
Likelihood ratio (LR): the ratio of the probability of a test result among patients with the target disorder to the probability of that same test result among patients who are free of the target disorder. The LR for a positive test is calculated as sensitivity/(1 — specificity). The LR for a negative test is calculated as (1 — sensitivity)/specificity.
Post-test odds: the odds that the patient has the target disorder after the test is carried out (pretest odds x LR).
Post-test probability: the proportion of patients with that particular test result who have the target disorder (post-test odds/[1 + post-test odds]).
|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- Long term use of eicosapentaenoic acid reduced major coronary events in hypercholesterolaemia
- L Kristin Newby
Evid. Based Med. 2007 12: 136. (in Therapeutics)[Extract] [Full Text] [PDF]
- Hormone therapy for younger women may not increase CHD risk during 5–7 years follow-up, but stroke risk was increased independent of age
- Robert L Reid
Evid. Based Med. 2007 12: 137. (in Therapeutics)[Extract] [Full Text] [PDF]
- The Atkins diet led to more weight loss than the Zone diet in overweight and obese premenopausal women at 12 months
- Raj Padwal
Evid. Based Med. 2007 12: 138. (in Therapeutics)[Extract] [Full Text] [PDF]
- A care management intervention improved depression after stroke
- David Ames
Evid. Based Med. 2007 12: 139. (in Therapeutics)[Extract] [Full Text] [PDF]
- A self-management approach to patient education for type 2 diabetes was more effective than a didactic approach
- Andrew Farmer
Evid. Based Med. 2007 12: 140. (in Therapeutics)[Extract] [Full Text] [PDF]
- Carvedilol was more effective than metoprolol for preventing cardiovascular events in heart failure
- Christopher B Granger
Evid. Based Med. 2007 12: 141. (in Therapeutics)[Extract] [Full Text] [PDF]
- An escalating higher energy regimen was better than a fixed lower energy regimen for defibrillation in out of hospital cardiac arrest
- Eddy S Lang
Evid. Based Med. 2007 12: 142. (in Therapeutics)[Extract] [Full Text] [PDF]
- 6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both
- Pieter W Kamphuisen
Evid. Based Med. 2007 12: 143. (in Therapeutics)[Extract] [Full Text] [PDF]
- Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children
- Samina Ali, Terry P Klassen
Evid. Based Med. 2007 12: 144. (in Therapeutics)[Extract] [Full Text] [PDF]
- A once yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis
- Bruce E Johnson
Evid. Based Med. 2007 12: 145. (in Therapeutics)[Extract] [Full Text] [PDF]
- 10 day sequential therapy was more effective than 10 day triple drug therapy for eradicating Helicobacter pylori infection
- Vincent Wai-Sun Wong, Francis Ka-Leung Chan
Evid. Based Med. 2007 12: 146. (in Therapeutics)[Extract] [Full Text] [PDF]
- Ambulatory titration of continuous positive airway pressure was as effective as polysomnography for obstructive sleep apnoea
- Joseph Golish, Octavian C Ioachimescu
Evid. Based Med. 2007 12: 148. (in Therapeutics)[Extract] [Full Text] [PDF]
-
Extract
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
